Way to the peptide vaccine against hepatitis C


1. Institute of Biomedical Chemistry, Moscow, Russia
Type: Review
DOI: 10.18097/PBMC20156102254      UDK: 615.371      PubMed Id: 25978391
Year: 2015 vol: 61  issue:2  pages: 254-264
Abstract: In order to surpass the problem of genetic variability of hepatitis C virus envelope proteins during vaccine development, we used the so-called “reverse vaccinology”approach – “from genome to vaccine”. Database of HCV protein sequences was designed, viral genome analysis was performed, and several highly conserved sites were revealed in HCV envelope proteins in the framework of this approach. These sites demonstrated low antigenic activity in full-size proteins and HCV virions: antibodies against these sites were not found in all hepatitis C patients. However, two sites, which contained a wide set of potential T-helper epitope motifs, were revealed among these highly conserved ones. We constructed and prepared by solid-phase peptide synthesis several artificial peptide constructs composed of two linker-connected highly conserved HCV envelope E2 protein sites; one of these sites contained a set of T-helper epitope motifs. Experiments on laboratory animals demonstrated that the developed peptide constructs manifested immunogenicity compared with one of protein molecules and were able to raise antibodies, which specifically bound HCV envelope proteins. We succeeded in obtaining antibodies reactive with HCV from hepatitis C patient plasma upon the immunization with some constructs. An original preparation of a peptide vaccine against hepatitis C is under development on the basis of these peptide constructs.
Download PDF:
Reference: Kolesanova E.F., Sobolev B.N., Moysa A.A., Egorova E.A., Archakov A.I., Way to the peptide vaccine against hepatitis C, Biomeditsinskaya khimiya, 2015, vol: 61(2), 254-264.
This paper is also available as the English translation:10.1134/S1990750815030026